Barbara Goodman Joins iBio as Its First Executive Director
Barbara Goodman has joined the Illinois Biotechnology Industry Organization as its first executive director, with oversight for iBIO’s entrepreneurial and international programs. She will report to iBIO President and CEO David Miller, who remains with the organization.
Those programs include Propel, a joint initiative of iBIO and the iBIO Institute aimed at increasing the number of life sciences start-ups in Illinois and boosting the success rates of existing companies. Barbara will also serve as general manager of the new iBIO Entrepreneurship Center, which provides technical assistance and seed-stage grants to startups, and is supported through a grant from the Illinois Department of Commerce and Economic Opportunity.
Previously, Barbara worked at the Rehabilitation Institute of Chicago as its director of corporate business development, where she was responsible for its diversification strategy, developing strategic alliances and partnerships with acute care hospitals beyond Illinois, business planning, consulting services, and due diligence.
She joined Cardinal Health in 2001, taking a business development position with Cardinal’s Medical Products and Services Division, also known as Allegiance Healthcare. In that role she assessed acquisition and licensing opportunities, developed strategic and market entry plans, and managed product commercialization projects.
Earlier in her career, Barbara was a member of Chesapeake Corp.’s corporate strategy and business development team, helping transform the pharmaceutical and specialty packaging company through six acquisitions, five divestitures, and two joint ventures. She also worked in strategic marketing for Bayer’s consumer care division in Leverkusen, Germany, and served as an advisor to the Chicago not-for-profit Bridge to Success, and the Costa Rican not-for-profit group Vida Marina Foundation.
Barbara earned her BA degree in international relations from the University of Minnesota and an MBA degree from Thunderbird School of Global Management.
UD Names Biotech Institute Director David Weir to New Economic Innovation Office
David Weir, the director of the Delaware Biotechnology Institute, has been named by the University of Delaware to lead its new Office of Economic Innovation and Partnerships, set to open July 1.
The new office was created late last year to promote innovation and entrepreneurship among UD professors by speeding up commercialization of technologies developed at the university, as well as to foster increased collaboration and stimulate regional economic development [Biotech Transfer Week, Nov. 12, 2007
Since 1998, Weir has served as the founding director of the public-private Delaware Biotechnology Institute. Previously, he had a 35-year career with DuPont, holding leadership positions in the business and scientific arenas. He participated in the discovery, development and marketing of DuPont product innovations in the polymer, fiber and agriculture business segments.
Weir, who holds a doctorate in chemical physics from the University of Glasgow, Scotland, lectured at the University of St. Andrews in Scotland before joining DuPont.
UD President Patrick Harker announced Weir’s appointment at "Creating a Livable Delaware: Pathways for Enhancing Prosperity and Quality of Life," a conference held March 25.
Catherine Nowicki Appointed to Rockland County, NY, Industrial Development Agency
Catherine Nowicki, a member of the Clarkstown, NY, town board, has been confirmed as the newest board member of the Rockland County, NY, Industrial Development Agency. The county board of legislators confirmed an appointment made earlier by County Executive C. Scot Vanderhoef.
Nowicki chaired an ad hoc committee to form an economic development strategy for Clarkstown as part of its 2005 effort to draft a comprehensive plan or guidelines for land use. The panel helped Clarkstown streamline its application process for development approvals, a reform the town credits with drawing 23 new small businesses now in various stages of relocating there.
In Rockland and elsewhere in New York state, IDAs provide tax breaks and other economic subsidies intended to attract or retain businesses and their jobs.
Webster Bank’s Rossi Honored by Connecticut Innovations for Biotech Support
John Rossi, senior vice president of Webster Bank’s emerging growth and technology group, has been honored for his support of biotech and other high-tech companies by Connecticut Innovations, the state's quasi-public authority for technology investing and innovation development.
Rossi joined Webster Bank in 2001 to establish the emerging growth group, arriving from Finova Capital Co. and a predecessor company, Financing for Science and Industry Inc. Rossi earlier held positions at Chase and Citibank, where he completed the Citibank credit training program. While at Citi, Rossi earned an MBA from the University of New Haven.